Modena confirms “40 million vaccine supply discussions with Korea”

Same as the announcement at the Blue House on the 29th
20 million people, supply in the second quarter of next year

US pharmaceutical company Modena’s COVID-19 vaccine. AFP Yonhap News

The US pharmaceutical company Modena said on the 29th (local time) that it is discussing to supply 40 million doses of a novel coronavirus infection (Corona 19) vaccine to Korea. The previous day, the Blue House confirmed the announcement after an agreement with Modena to supply the vaccine.

In an official press release on the day, “We are discussing to provide 40 million doses or more to support the Korean government’s goal of distributing the vaccine as soon as possible.” Will begin.” Because Modena vaccine has to be given twice, 20 million people can be vaccinated in 40 million doses.

Earlier, the Blue House said in a phone call with President Moon Jae-in on the 28th that the company had agreed to supply 20 million vaccines to South Korea. It is twice as many as the 10 million people negotiating. Specific contracts will be concluded within the year. As a result, Korea has secured vaccines for a total of 56 million people. AstraZeneca’s 10 million people, Janssen’s 6 million people, Pfizer’s 10 million people, and 10 million people through the international project Cobax for joint purchase and distribution of vaccines.

Moderna explained in a press release that day, “The forward-looking statements contained in the statements are neither promises nor warranties, and actual results may vary.” Previously, Modena announced that almost all COVID-19 vaccine approval and sales press releases, including the EU’s 80 million dose option exercise on the 18th and the vaccine approval in Canada on the 23rd, predicted the future under the Securities Private Litigation Reform Act of 1995 It contains statements.’ This is the nature of a’warning’ to avoid class action lawsuits, as there has been no commercial vaccine product using the’mRNA (ribonucleic acid)’ method, and manufacturing and supply schedules may be delayed.

Kim Pyo-hyang reporter




Subscribe to the Hankook Ilbo News Naver Channel
Subscribe on Newsstand

Balance to see the world, the Hankook Ilbo Copyright © Hankookilbo

Issues you may be interested in

.Source